Our study provides compelling evidence of a multilineage functional relationship between DPF2-BAF complexes and the KEAP1/NRF2 pathway and establishes a scientific basis for therapeutic interventions in chronic inflammatory disorders, neurodegenerative diseases, and cancers driven by DPF2-BAF complex mutations. The gene discussed is NFE2L2; the disease is cancer.